Latest News

Yale School of Medicine teams have received three grants totaling $18 million from Aligning Science Across Parkinson’s (ASAP), a coordinated research initiative devoted to accelerating the pace of discovery and informing the path to a cure for Parkinson’s disease (PD) research.

Erol Fikrig, MD, is honored for his work leading to a Lyme disease vaccine, and Haifan Lin, PhD, is recognized for two "hallmark" stem cell theories.

The new Yale center is the first to focus on developing precision medicine for Parkinson’s disease.

Gillian Griffiths, PhD, has been appointed chair of the Department of Cell Biology. On April 1, 2025, Griffiths will join Yale School of Medicine (YSM) from the Cambridge Institute for Medical Research at the University of Cambridge, where she is currently a professor and Wellcome Trust Principal Research Fellow and previously served as institute director.

Two Yale Cancer Center members are among six Yale researchers to receive High-Risk, High-Reward NIH grants.

In a recent review article, a YSM pathologist described existing technologies for monitoring CAR T-cell therapy and important avenues for future research.

Our body’s most common immune cells have a reputation for destruction and inflammation. Now, researchers are beginning to realize there’s another side to the neutrophil.

Yale researchers recently published a paper in Nature Cardiovascular Research investigating pathways that regulate vessels that remodel to become larger (or outward remodeling). The paper identified a specific antibody that targets this pathway and suggests that it is a potential therapeutic approach for ischemic disease.